GAMBACORTI PASSERINI, CARLO
GAMBACORTI PASSERINI, CARLO
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients
2023 Malighetti, F; Arosio, G; Manfroni, C; Mauri, M; Villa, M; Manghisi, B; Inzoli, E; Rindone, G; Zambrotta, G; Civettini, I; Guglielmana, V; Ramazzotti, D; Giudici, G; Bombelli, S; Perego, R; Piazza, R; Mologni, L; Gambacorti-Passerini, C
Long-term safety review of tyrosine kinase inhibitors in chronic myeloid leukemia - What to look for when treatment-free remission is not an option
2022 Lipton, J; Brummendorf, T; Gambacorti Passerini, C; Garcia-Gutierrez, V; Deininger, M; Cortes, J
Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX-IOL study
2022 Elli, E; Di Veroli, A; Bartoletti, D; Iurlo, A; Carmosino, I; Benevolo, G; Abruzzese, E; Bonifacio, M; Bergamaschi, M; Polverelli, N; Caramella, M; Cilloni, D; Tiribelli, M; Pugliese, N; Caocci, G; Crisa, E; Porrini, R; Markovic, U; Renso, R; Auteri, G; Cattaneo, D; Trawinska, M; Scaffidi, L; Biale, L; Bucelli, C; Breccia, M; Gambacorti Passerini, C; Palumbo, G; Latagliata, R; Palandri, F
Tyrosine Kinase Inhibitor discontinuation in Chronic Myeloid Leukemia: eligibility criteria and predictors of success
2022 Inzoli, E; Aroldi, A; Piazza, R; Gambacorti Passerini, C
Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma
2022 Karaca Atabay, E; Mecca, C; Wang, Q; Ambrogio, C; Mota, I; Prokoph, N; Mura, G; Martinengo, C; Patrucco, E; Leonardi, G; Hossa, J; Pich, A; Mologni, L; Gambacorti Passerini, C; Brugieres, L; Geoerger, B; Turner, S; Voena, C; Cheong, T; Chiarle, R
Imbalanced Angiogenesis in Pregnancies Complicated by SARS-CoV-2 Infection
2022 Giardini, V; Ornaghi, S; Gambacorti-Passerini, C; Casati, M; Carrer, A; Acampora, E; Vasarri, M; Arienti, F; Vergani, P
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study
2022 Visco, C; Marcheselli, L; Mina, R; Sassone, M; Guidetti, A; Penna, D; Cattaneo, C; Bonuomo, V; Busca, A; Ferreri, A; Bruna, R; Petrucci, L; Cairoli, R; Salvini, M; Bertu, L; Ladetto, M; Pilerci, S; Pinto, A; Ramadan, S; Marchesi, F; Cavo, M; Arcaini, L; Coviello, E; Romano, A; Musto, P; Massaia, M; Fracchiolla, N; Marchetti, M; Scattolin, A; Tisi, M; Cuneo, A; Porta, M; Trentin, L; Turrini, M; Gherlinzoni, F; Tafuri, A; Galimberti, S; Bocchia, M; Cardinali, V; Cilloni, D; Corso, A; Armiento, D; Rigacci, L; La Barbera, E; Gambacorti Passerini, C; Visani, G; Vallisa, D; Venditti, A; Selleri, C; Conconi, A; Tosi, P; Lanza, F; Candoni, A; Krampera, M; Corradini, P; Passamonti, F; Merli, F
Treatment patterns and clinical outcomes of tyrosine kinase inhibitors in chronic-phase CML in clinical practice: 3-year European SIMPLICITY data
2021 Gambacorti Passerini, C; Chen, C; Davis, C; Sen, G; Guyan, C; Hehlmann, R; Michallet, M; Paquette, R; Goldberg, S
Being a Myeloproliferative Patient in COVID-19 Era: The Mytico Study
2021 Cavalca, F; Renso, R; Zambrotta, G; Gambacorti Passerini, C; Elli, E
VERSO: a comprehensive framework for the inference of robust phylogenies and the quantification of intra-host genomic diversity of viral samples
2021 Ramazzotti., D; Angaroni, F; Maspero, D; Gambacorti-Passerini, C; Antoniotti, M; Graudenzi, A; Piazza, R
Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019
2021 Aroldi, A; Chiarle, R; Gambacorti Passerini, C
Long-term cardiac, vascular, hypertension, and effusion safety of bosutinib in patients with Philadelphia chromosome–positive leukemia resistant or intolerant to prior therapy
2021 Cortes, J; Kantarjian, H; Mauro, M; An, F; Nick, S; Leip, E; Gambacorti Passerini, C; Brummendorf, T
Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies
2021 Gambacorti Passerini, C; Ruggeri, M; Aroldi, A; Piazza, R; Mazzi, A; De Silvestro, G; Krampera, M; Lanza, F
Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma
2021 Arosio, G; Sharma, G; Villa, M; Mauri, M; Crespiatico, I; Fontana, D; Manfroni, C; Mastini, C; Zappa, M; Magistroni, V; Ceccon, M; Redaelli, S; Massimino, L; Garbin, A; Lovisa, F; Mussolin, L; Piazza, R; Gambacorti Passerini, C; Mologni, L
STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma
2021 Lobello, C; Tichy, B; Bystry, V; Radova, L; Filip, D; Mraz, M; Montes-Mojarro, I; Prokoph, N; Larose, H; Liang, H; Sharma, G; Mologni, L; Belada, D; Kamaradova, K; Fend, F; Gambacorti Passerini, C; Merkel, O; Turner, S; Janikova, A; Pospisilova, S
Letter to the editor: Sflt-1 and plgf levels in pregnancies complicated by sars-cov-2 infection
2021 Giardini, V; Ornaghi, S; Acampora, E; Vasarri, M; Arienti, F; Gambacorti Passerini, C; Casati, M; Carrer, A; Vergani, P
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies
2021 Passamonti, F; Romano, A; Salvini, M; Merli, F; Porta, M; Bruna, R; Coviello, E; Romano, I; Cairoli, R; Lemoli, R; Farina, F; Venditti, A; Busca, A; Ladetto, M; Massaia, M; Pinto, A; Arcaini, L; Tafuri, A; Marchesi, F; Fracchiolla, N; Bocchia, M; Armiento, D; Candoni, A; Krampera, M; Luppi, M; Cardinali, V; Galimberti, S; Cattaneo, C; La Barbera, E; Mina, R; Lanza, F; Visani, G; Musto, P; Petrucci, L; Zaja, F; Grossi, P; Bertu, L; Pagano, L; Corradini, P; Derenzini, E; Marchetti, M; Scattolin, A; Corso, A; Tosi, P; Gherlinzoni, F; Gambacorti Passerini, C; Cavo, M; Fava, C; Turrini, M; Visco, C; Zappasodi, P; Merli, M; Mora, B; Vannucchi, A
Efficacy and safety following bosutinib dose reduction in patients with Philadelphia chromosome‒positive leukemias
2021 Kota, V; Brummendorf, T; Gambacorti Passerini, C; Lipton, J; Kim, D; An, F; Leip, E; Crescenzo, R; Ferdinand, R; Cortes, J
Whole exome sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target
2021 Larose, H; Prokoph, N; Matthews, J; Schlederer, M; Hogler, S; Alsulami, A; Ducray, S; Nuglozeh, E; Fazaludeen, M; Elmouna, A; Ceccon, M; Mologni, L; Gambacorti Passerini, C; Hoefler, G; Lobello, C; Pospisilova, S; Janikova, A; Woessmann, W; Damm-Welk, C; Zimmermann, M; Fedorova, A; Malone, A; Smith, O; Wasik, M; Inghirami, G; Lamant, L; Blundell, T; Klapper, W; Merkel, O; Amos Burke, G; Mian, S; Ashankyty, I; Kenner, L; Turner, S
Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia
2021 Fontana, D; Gambacorti Passerini, C; Piazza, R